Troy A. Ignelzi

Chief Financial Officer at Rapport Therapeutics · 1 reported transaction in 1 company · latest trade Oct 21, 2026

Their record

No purchases old enough to measure yet.


Rapport TherapeuticsRAPP	Bought $143.6K · 5,500 shares	Oct 21, 2026	S&P 500 −2.3%thru Oct 30

Oct 21, 2026 · RAPP

$143.6K

S&P 500 −2.3%thru Oct 30

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Rapport Therapeutics · 1 reported transaction in 1 company · latest trade Oct 21, 2026

No purchases old enough to measure yet.


Rapport TherapeuticsRAPP	Bought $143.6K · 5,500 shares	Oct 21, 2026	S&P 500 −2.3%thru Oct 30

Oct 21, 2026 · RAPP

$143.6K

S&P 500 −2.3%thru Oct 30

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.